Sun, Aug 25 5:10am

Compare CLVS

Clovis Oncology Inc [CLVS]
$5.95 0.06 (1.02%)

CLVS Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 330 Million
CLVS Description

Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, the EU, and additional international markets. The firm target its development programs for the treatment of specific subsets of cancer populations. Its product candidates include Rucaparib and Lucitanib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer whereas Lucitanib includes Rucaparib Combo and Nivolumab Combo.

Visit Website

CLVS Earnings

EPS -2.27 P/E Ratio 0.00
Previous Earnings Tue, May 7, 2019
Latest Earnings Thu, Aug 1, 2019 (24 days ago) -43.60%

CLVS Dividend

Yield --
Ex-Date --
Pay Date --
History --

CLVS Charts

1 Year
Aug 15, 2019
Aug 29, 2018

Symbol Price Day % YTD %
CLVS $5.95 1.02% -69.31%

Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy